Top compounds associated with response to NR2C1


Feature Type Standardized
Nominal ANOVA
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.075 0.03
mRNA manumycin A CTRPv2 pan-cancer AAC 0.072 0.03
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.12 0.03
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC -0.09 0.03
mRNA AS605240 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.079 0.03
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.065 0.03
mRNA FH535 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.075 0.03
Download CSV